A study of the safety, tolerability and effectiveness of EZM0414 investigative product in participants with Relapsed/refractory Multiple Myeloma and Relapsed/refractory Diffuse Large B Cell Lymphoma
A study to assess long-term safety of tazemetostat in adult participants of all ages with any disease treated with tazemetostat in a previous clinical study